Evidence map›Paper›PMID 36626013›Full record

ArticleCerebellum (London, England)2024

Development and Optimization of a Multilayer Rat Purkinje Neuron Culture.

Ida Margrethe Uggerud, Torbjørn Kråkenes, Hirokazu Hirai, Christian Alexander Vedeler, Manja Schubert

Open access · hybridAbstract read
In one paragraph

Article in Cerebellum (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration.Annals of clinical and translational neurology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ida Margrethe Uggerud *Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway.
Torbjørn Kråkenes *Department of Clinical Medicine (K1), University of Bergen, 5021, Bergen, Norway.
Hirokazu HiraiDepartment of Neurophysiology &, Neural Repair, Gunma University Graduate School of Medicine, Maebashi, Gunma, 371-8511, Japan.
Christian Alexander VedelerDepartment of Neurology, Haukeland University Hospital, 5021, Bergen, Norway.
Manja SchubertDepartment of Neurology, Haukeland University Hospital, 5021, Bergen, Norway. schubert_manja@hotmail.com.
University of Bergen · NOGunma University · JPHaukeland University Hospital · NO

Funding

HelseVest Norway Christian A. VedelerUniversitetet i Bergen PhD grant #2016/7580-RAKA
6 · The paper itself

Abstract

Elucidation of the mechanisms involved in neurodegenerative diseases of the cerebellum has been hampered by the lack of robust single cell models to study Purkinje neurons and replicate at the same time in vivo features. Cerebellar Purkinje neurons are difficult to grow in dispersed cell culture, and only limited work has been done using rat cells. We developed a refined protocol for growing rat Purkinje neurons from embryonic and postnatal tissue ex vivo that results in well-developed, mature, functional, and synaptically active neurons. The rat Purkinje neurons generated are responsive to paracrine factors and genetic manipulation, allowing great experimental flexibility at the single-cell level. This ex vivo model can be used to investigate disease mechanisms that disturb Purkinje neuron morphology, function, and communication in high- and low-throughput screening formats.

Indexed as

CerebellumPurkinje CellsAnimalsCell Culture TechniquesNeuronsRatsEx vivo culture system; Rat Purkinje neuronsThree-dimensional cerebellar network

Identifiers

PMID36626013
PMCPMC10864459
OpenAlexW4313946040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.